Omass
Founded 2016 · 4 known investors
OMass uses native mass spectrometry, proprietary biochemistry and custom chemistry to study drug targets and their interactions with their native biological environment outside the confounding complexity of the cell. It operates in drug discovery within the biotech/pharmaceutical sector.
BiotechDeep TechHealthtech
Founders & leadership
RD
Ros Deeganin
Investors · 4
Frequently asked questions
- What does Omass do?
- OMass uses native mass spectrometry, proprietary biochemistry and custom chemistry to study drug targets and their interactions with their native biological environment outside the confounding complexity of the cell. It operates in drug discovery within the biotech/pharmaceutical sector.
- Who are Omass's investors?
- Omass's investors include GV (Google Ventures), Oxford Science Enterprises, Sanofi Ventures, Syncona.